🔴 Website 👉 https://u-s-news.com/
Telegram 👉 https://t.me/usnewscom_channel
Former NFL quarterback Brett Favre revealed he has Parkinson’s disease during a House Ways and Means Committee hearing on Tuesday.
Brett Favre testified before the committee about Prevacus, a company working on a concussion drug that took $2 million from Mississippi’s welfare fund (TANF).
Prevacus’s founder admitted to wire fraud and confessed to using welfare money for gambling debts.
“Sadly, I also lost an investment in a company that I believed was developing a breakthrough concussion drug I thought would help others,” Brett Favre stated. “And I’m sure you’ll understand why it’s too late for me, because I’ve recently been diagnosed with Parkinson’s. This is also a cause dear to my heart.”
WATCH:
Hall-of-Fame QB Brett Favre announced that he recently was diagnosed with Parkinson’s Disease. pic.twitter.com/dU0RL0nmsH
— Adam Schefter (@AdamSchefter) September 24, 2024
Excerpt from ESPN:
Hall of Fame quarterback Brett Favre disclosed during a congressional hearing on Tuesday that he was recently diagnosed with Parkinson’s disease, a degenerative nervous system disorder that causes parts of the brain to deteriorate and affects movement.
Speaking before the House Ways and Means Committee, Favre spoke about Prevacus, a company making a concussion drug that received $2 million of Temporary Assistance for Needy Families (TANF) funds. Favre was the top investor in Prevacus, and text messages show he began asking state officials for help securing funds for the company in November 2018.
Prevacus’s founder, Jacob VanLandingham, pleaded guilty to wire fraud in July, admitting that he used Mississippi welfare money to pay off gambling and other debts.
Favre spoke about his involvement in a sprawling Mississippi welfare case. At least $77 million in TANF funds, earmarked for poor families, were diverted to the rich and powerful, according to a 2019 Mississippi state audit.
As reported by the Gateway Pundit, for more details, you can read the original article here.